Shionogi & Co., Ltd. (TYO:4507)
2,651.50
-43.00 (-1.60%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Pharmaceutical | 438.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | 6.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Other | 19.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 7.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | 245.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Growth | 21.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 130.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | -16.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 23.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 29.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 20.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 13.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 19.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 7.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|